Protocols commonly use 200500 mcg subcutaneously, once or twice daily, in 46 week cycles, but there is no FDA-approved product or official dosing
Retatrutide uniquely binds to GLP-1, GIP, and glucagon receptors
We frequently mention research chemicals that are not made for human consumption
Here's why BPC-157 is different: "Is This Just Another Trend?" BPC-157 has been studied for decades for its healing and regenerative properties
Those effects link to processes relevant to reproductive aging: follicle survival, oocyte quality, ovarian inflammation, and tissue repair
In one study on rat models, cytokine therapy designed to promote angiogenesis and stimulate endothelial growth was proven to effectively treat ED